This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing Vyjuvek uptake in patients with dystrophic epidermolysis bullosa (DEB)

Ticker(s): KRYS

Who's the expert?

Institution:  Stanford University

  • Clinical professor of Dermatology and Pediatrics at the Department of Dermatology at Stanford and Chief of Pediatric Dermatology.
  • Currently treats 4-6 RDEB patients each month.
  • Dr. Teng is an active physician scientist with strong interest and expertise in clinical and translational research especially in the area of rare genetic disorders. She is experienced in drug repurposing and trans-epidermal drug delivery and directs multidisciplinary care of patients with complex dermatologic conditions, genetic skin disease and vascular anomalies.

Interview Goal
prescriber check-in at an academic institution

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.